Cholinergic systems and alzheimer's disease
- 1 January 1988
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 14 (2) , 95-109
- https://doi.org/10.1002/ddr.430140202
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Decreased muscarinic receptor binding in cerebral cortex and hippocampus in alzheimer's diseaseLife Sciences, 1987
- Oral Tetrahydroaminoacridine in the Treatment of Senile Dementia, Alzheimer's TypeNew England Journal of Medicine, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Patients with Alzheimer's disease show an increased content of 15Kdalton somatostatin precursor and a loweredLife Sciences, 1986
- Alzheimer??s Disease Is It Worth Treating?Drugs, 1985
- Striatal dopamine receptors in Alzheimer-type dementiaNeuroscience Letters, 1984
- Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer typeNeuroscience Letters, 1984
- Effects of Naloxone in Senile Dementia: A Double-Blind TrialNew England Journal of Medicine, 1983
- DOPAMINE IN ALZHEIMER'S DISEASE AND SENILE DEMENTIAThe Lancet, 1979
- Choline chloride in methylphenidate- and apomorphine-induced stereotypyLife Sciences, 1978